CVRx (CVRX) Cash from Operations (2020 - 2026)
CVRx's (CVRX) quarterly Cash from Operations came in at 12164000.0 in Q1 2026, up 4.72% year-on-year from 11615391.77 in Q1 2025, and down 24.66% quarter-over-quarter from 9758000.0 in Q4 2025.
CVRx (CVRX) Cash from Operations (2020 - 2026) Analysis & Trends
CVRx's Cash from Operations history runs 7 years deep, the most recent figure standing at 12164000.0 for Q1 2026.
- On a quarterly basis, Cash from Operations rose 4.72% year-over-year to 12164000.0 in Q1 2026; TTM through Mar 2026 was 39567000.0, a 3.53% increase from a year earlier, with the FY2025 full-year figure at 40170000.0, down 2.62% from the prior year.
- Cash from Operations retreated to 12164000.0 in Q1 2026 per CVRX's latest filing, from 9758000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 7839000.0 in Q4 2023 and bottomed at 12808000.0 in Q2 2023.
- The 5-year median for Cash from Operations is 10249000.0 (2023), against an average of 10186823.53.
- Across the five-year window, Cash from Operations tumbled 111.27% in 2022 and climbed 27.69% in 2023, its largest moves.
- Year by year, Cash from Operations stood at 10841000.0 in 2022, then gained by 27.69% to 7839000.0 in 2023, then dropped by 2.16% to 8008000.0 in 2024, then decreased by 21.85% to 9758000.0 in 2025, then fell by 24.66% to 12164000.0 in 2026.
- Per Business Quant, the three latest CVRX Cash from Operations figures stand at 12164000.0 (Q1 2026), 9758000.0 (Q4 2025), and 9709000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.32 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 581.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.57 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 348.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 43.80 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 525.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 220.10 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 290.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | CVRx | 128.88 Mn | 56.58 Mn | 12.88 Mn | -12.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.16 Mn |
| Mar 31, 2026 | -12.16 Mn |
| Dec 31, 2025 | -9.76 Mn |
| Dec 31, 2025 | -9.76 Mn |
| Sep 30, 2025 | -9.71 Mn |
| Sep 30, 2025 | -9.71 Mn |
| Jun 30, 2025 | -7.94 Mn |
| Jun 30, 2025 | -7.94 Mn |
| Mar 31, 2025 | -12.77 Mn |
| Mar 31, 2025 | -12.77 Mn |
| Dec 31, 2024 | -8.01 Mn |
| Dec 31, 2024 | -8.01 Mn |
| Sep 30, 2024 | -10.41 Mn |
| Sep 30, 2024 | -10.41 Mn |
| Jun 30, 2024 | -9.83 Mn |
| Jun 30, 2024 | -9.83 Mn |
| Mar 31, 2024 | -10.90 Mn |
| Mar 31, 2024 | -10.90 Mn |
| Dec 31, 2023 | -7.84 Mn |
| Dec 31, 2023 | -7.84 Mn |